SIMPLEX TRADING, LLC - BRAINSTORM CELL THERAPEUTICS ownership

BRAINSTORM CELL THERAPEUTICS's ticker is BCLI and the CUSIP is 10501E201. A total of 49 filers reported holding BRAINSTORM CELL THERAPEUTICS in Q1 2023. The put-call ratio across all filers is 1.31 and the average weighting 0.1%.

Quarter-by-quarter ownership
SIMPLEX TRADING, LLC ownership history of BRAINSTORM CELL THERAPEUTICS
ValueSharesWeighting
Q1 2023$605
+3261.1%
183,390
+1559.9%
0.00%
Q4 2022$1811,048
+5424.0%
0.00%
Q3 2022$02000.0%0.00%
Q2 2022$0
-100.0%
200
-91.6%
0.00%
Q1 2022$7,0002,378
+1089.0%
0.00%
Q4 2021$02000.0%0.00%
Q3 2021$02000.0%0.00%
Q2 2021$02000.0%0.00%
Q1 2021$02000.0%0.00%
Q4 2020$0
-100.0%
200
-77.8%
0.00%
Q3 2020$15,000
-76.2%
900
-94.4%
0.00%
Q2 2019$63,000
+231.6%
15,979
+256.4%
0.00%
Q1 2019$19,000
+171.4%
4,484
+99.5%
0.00%
Q4 2018$7,0002,248
+1287.7%
0.00%
Q3 2018$0
-100.0%
162
-94.4%
0.00%
Q2 2018$11,000
+1000.0%
2,894
+436.9%
0.00%
Q1 2018$1,000
-75.0%
539
-50.0%
0.00%
Q4 2017$4,0001,078
+485.9%
0.00%
Q2 2017$0
-100.0%
184
-97.6%
0.00%
-100.0%
Q1 2017$32,000
+357.1%
7,703
+151.8%
0.00%
Q4 2016$7,000
+75.0%
3,059
+70.7%
0.00%
Q3 2015$4,0001,792
+179100.0%
0.00%
Q2 2015$010.00%
Other shareholders
BRAINSTORM CELL THERAPEUTICS shareholders Q1 2023
NameSharesValueWeighting ↓
ABNER HERRMAN & BROCK LLC 241,500$1,093,0000.17%
OCCUDO QUANTITATIVE STRATEGIES LP 90,584$410,0000.13%
EPIQ PARTNERS, LLC 10,550$48,0000.03%
Phoenix Holdings Ltd. 173,683$799,0000.02%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 5,500$25,0000.02%
CFO4Life Group, LLC 12,003$54,0000.02%
HighPoint Advisor Group LLC 15,733$115,0000.01%
VOLORIDGE INVESTMENT MANAGEMENT, LLC 357,761$1,619,0000.01%
Virtu Financial LLC 24,484$111,0000.01%
ETF MANAGERS GROUP, LLC 93,902$435,0000.01%
View complete list of BRAINSTORM CELL THERAPEUTICS shareholders